Class of 2013 Abstract / Specific Aims: To assess the effect of a pharmacist-led education group on psychiatric patient-reported attitudes, knowledge, and confidence in self-managing medications. The reliability and validity of the questionnaire given to patients who attended a pharmacist-led medication education group was also evaluated. Methods: A retrospective pre-post questionnaire was distributed patients and collected variables collected including patient self-reported medication knowledge and attitudes, demographics, previous psychiatric hospitalizations, length of group attended, and outpatient pharmacist relationships. Knowledge and attitude items were measured on a 4-point Likert-type scale with response options ranging from “agree” to “disagree.” Rasch analysis was conducted to ensure all items measured the same construct and the probability of the person responding to an item was not dependent on other assessment items. Rasch measurement includes several diagnostic indices that allow item-specific and person-specific examinations of data reliability and measurement fit. In addition, the Rasch technique makes it possible to evaluate the contribution of each person’s measures on each item. A z-test was used to evaluate for instrument content gaps and a dependent t-test was performed to measure for statistical differences before and after the intervention. Main Results: Sixty patients responded to the Medication Attitude and Knowledge Questionnaire over a 16-week period. Gaps identified were not statistically significant (p=0.1064 and 0.5305) indicating that content validity is comprehensive. On a group level, no significant differences were identified in patient answers before and after the intervention (p=0.2162, p=0.8292). When each patient was analyzed separately, only one patient out of 60 showed a significant difference in answers after the intervention. Results also demonstrated that after attending a group, 100% of patients indicated they intended to adhere to their medication regimen post-discharge. Conclusion: This evaluation was unique because patient attitudes were explored before and after medication education group attendance. Medication Attitude and Knowledge items were valid and reliable.

No description available.

Background Of the 464 million patients diagnosed with diabetes mellitus globally, type 2 diabetes accounts for 90%. Type 2 diabetes contributes to other conditions such as hypertension, dyslipidaemia and cardiovascular diseases. Glycaemic haemoglobin control is essential in reducing long-term macrovascular and microvascular complications. Pharmacist interventions have been documented to have a positive role in diabetes management. In Kuwait, type 2 diabetes prevalence is increasing and found in a young population. Aims To evaluate the influence of the pharmacist-led intervention on diabetes knowledge, medication adherence and HbA1c, and hypertension. In addition, to estimate the 10-years risk of developing cardiovascular events and assess the cost of diabetes-related complications. Method The study was a randomised controlled trial with control and intervention arms conducted at the military hospital in Kuwait. Participants (n=177) were randomly allocated to the intervention group (n=88) and control group (n=89), using a 4-block randomisation procedure. The intervention group received face-to-face education and counselling from the pharmacist with a monthly follow-up for six months. The primary outcome was glycaemic control, and secondary measures were hypertension, lipid profiles, medication adherence, diabetes knowledge, 10-year estimated cardiovascular events and cost. QRISK3 and UKPDS-OM2 were used to estimate the risk of CVD events and cost comparison analysis. ii Results Compared with baseline, the mean reduction of HbA1c, blood pressure, and lipid profiles showed significant improvement in the intervention group. Additionally, improvement in medication adherence, diabetes knowledge, 10-years estimated cardiovascular events were reported with the intervention group. Also, the pharmacist-led intervention was cost-saving. Conclusion The study highlighted that adult type 2 diabetes patients who received the pharmacist-led intervention experienced a reduction in adverse clinical outcomes, improved non-clinical outcomes, and assisted in lifestyle modification.